SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Minerco Resources Inc (OTCMKTS:MINE) the parent firm of Level 5 Beverage Company, Inc. issued a letter to its shareholders addressed from CEO and Chairman, V. Scott Vanis. The CEO said that the recent quarterly report was a mixed report with equal hits and misses.

The trajectory of achievement and progress in last one year is impressive. The overall growth strategy of creating increased value for shareholders and accumulating more equity holdings is the right course and is directing the company to its objective of up grading to a reputed listed exchange.

The positives

Talking about the progress, Mr. Vanis said that assets are $3.5 million up almost $800,000 from January 31, 2015. This increase can be attributed to Minerco’s acquisition of cash flowing assets, like increased stake in Avanzar Sales & Distribution, the product VitaminFIZZ, and also to interest accruing notes receivable.

The derivative liabilities declined almost $700,000 from previous quarter. The company is consistently working to minimize overall debt burden. It is essential for company to emerge from a small cap platform to a listed exchange.

The plans

Minerco is fully divested of its remaining clean energy projects. The acquisition price was in the form of the allocation of more than $32,000 of Minerco debt, and obtaining an interest accruing ‘Note’ receivable of over $680,000. This deal adds over $700,000 in gross assets to company’s balance sheet.

Minerco Resources Inc (OTCMKTS:MINE) has completely closed former line of operations and are now just focused on the beverage industry and expanding flagship beverage, VitaminFIZZ, to all markets across the U.S. The company’s incremental revenues surged $33,000 year-over-year, with over $600,000 in sales in 3Q2015.

The buzz

The increase in incremental revenues can be attributed to increased VitaminFIZZ sales partially offset by lower sales of other Avanzar products affected by seasonality. The lead product, VitaminFIZZ is consistently recording increased sales momentum in domestic test markets.

SHARE
Previous articleCOASTAL INTGRTD SVCS (OTCMKTS:COLV) Back Into Action
Next articleCollabRx Inc (NASDAQ:CLRX) Trades Below The $1.00 Mark
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.